Concepedia

A Pogrebniak

AP

5

Publications

183

Citations

5

H-Index

1999

Active since

Affiliations

LMU Klinikum(Current)

A Pogrebniak is an author at LMU Klinikum specializing in medicine, cell death, and cancer research.

Top concepts

MedicineApoptosisCell DeathCell BiologyPharmacologyCancer ResearchOncologyAutophagyMitophagyHematology

Publications per year

1999–2006

5

Publications

5

Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.

A Pogrebniak, Isabel Schemainda, K Azzam et al. · PubMed · 2006 · 61 citations

Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines

V. Nuessler, Oliver Stötzer, E. Gullis et al. · Leukemia · 1999 · 47 citations · Full text

Hematological Malignancy, Tumor Biology, Mixed-phenotype Acute Leukemia +8

Drug-induced apoptosis in chronic lymphocytic leukemia

OJ Stoetzer, A Pogrebniak, Melissa Scholz et al. · Leukemia · 1999 · 37 citations

Hematological Malignancy, Oncology, Medicine +7

Modulation of apoptosis by mitochondrial uncouplers: apoptosis-delaying features despite intrinsic cytotoxicity

Oliver J. Stoetzer, A Pogrebniak, R. Pelka‐Fleischer et al. · Biochemical Pharmacology · 2002 · 27 citations

Mitophagy, Mitochondrial Uncouplers, Biochemistry +11

Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.

A Pogrebniak, Isabel Schemainda, R. Pelka‐Fleischer et al. · PubMed · 2003 · 11 citations

Rows per page

1–5 of 5